Phase I clinical trial of an acellular pertussis vaccine composed of genetically detoxified pertussis toxin combined with FHA and 69 kDa (Q40744386)

23 September 2017

Phase I clinical trial of an acellular pertussis vaccine composed of genetically detoxified pertussis toxin combined with FHA and 69 kDa (English)

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90290-M

17 November 2022

main subject

phase I clinical trial

0 references

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1759492

Bordetella virulence factors

17 November 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1759492

17 November 2022

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90290-M

17 November 2022

9

Rappuoli R

1 reference

23 September 2017

4

S. Peppoloni

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1759492

17 November 2022

author name string

A. Podda

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1759492

17 November 2022

L. Nencioni

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1759492

17 November 2022

I. Marsili

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1759492

17 November 2022

G. Volpini

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1759492

17 November 2022

D. Donati

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1759492

17 November 2022

A. Di Tommaso

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1759492

17 November 2022

M. T. De Magistris

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1759492

17 November 2022

language of work or name

English

0 references

publication date

1 October 1991

1 reference

full work available at URL

23 September 2017

https://api.elsevier.com/content/article/PII:0264410X9190290M?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90290-M

https://api.elsevier.com/content/article/PII:0264410X9190290M?httpAccept=text/plain

17 November 2022

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90290-M

17 November 2022

1 reference

23 September 2017

9

1 reference

23 September 2017

10

1 reference

23 September 2017

741-745

1 reference

Haemophilus influenzae infections and whooping cough

23 September 2017

1

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90290-M

Secondary analyses of the efficacy of two acellular pertussis vaccines evaluated in a Swedish phase III trial

17 November 2022

3

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90290-M

Properties of pertussis toxin mutant PT-9K/129G after formaldehyde treatment

17 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90290-M

Mortality and morbidity from invasive bacterial infections during a clinical trial of acellular pertussis vaccines in Sweden.

17 November 2022

6

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90290-M

Mutants of pertussis toxin suitable for vaccine development

17 November 2022

7

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90290-M

Characterization of genetically inactivated pertussis toxin mutants: candidates for a new vaccine against whooping cough

17 November 2022

8

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90290-M

Metabolic, humoral, and cellular responses in adult volunteers immunized with the genetically inactivated pertussis toxin mutant PT-9K/129G.

17 November 2022

9

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90290-M

Filamentous hemagglutinin of Bordetella pertussis: nucleotide sequence and crucial role in adherence

17 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90290-M

Protein measurement with the Folin phenol reagent

17 November 2022

14

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90290-M

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

17 November 2022

15

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90290-M

The standardization of an assay for pertussis toxin and antitoxin in microplate culture of Chinese hamster ovary cells.

17 November 2022

17

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90290-M

Clinical, metabolic, and antibody responses of adult volunteers to an investigational vaccine composed of pertussis toxin inactivated by hydrogen peroxide

17 November 2022

21

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90290-M

17 November 2022

Identifiers

1 reference

23 September 2017

1 reference